Zeltiq

Zeltiq, also known as CoolSculpting, is a non-invasive cosmetic procedure designed to reduce localised fat deposits in the body. It uses controlled cooling technology to target and freeze fat cells, leading to their gradual elimination from the body.

Zeltiq is recommended for individuals who have localised pockets of fat that are resistant to diet and exercise. It is not intended for overall weight loss but rather for body contouring. Common treatment areas include the abdomen, thighs, flanks (love handles), and submental area (under the chin).

The benefits of Zeltiq include: • Non-invasive: Zeltiq is a non-surgical procedure that does not require incisions, anaesthesia, or downtime. • Fat reduction: It can help reduce fat bulges and improve body contouring. • Minimal discomfort: Patients may experience mild discomfort during treatment but can typically resume normal activities afterward. • Gradual results: Results develop over several weeks as the body naturally eliminates fat cells. • Long-lasting: Fat cells treated with Zeltiq are permanently eliminated.

Contraindications for Zeltiq may include: • Obesity: Zeltiq is not a weight loss solution and is not suitable for individuals with significant excess weight. • Certain medical conditions: Individuals with certain medical conditions or skin conditions may not be suitable candidates. • Pregnancy and breastfeeding: It is not recommended for pregnant or breastfeeding individuals.

Zeltiq works based on the principle of cryolipolysis, which is the application of controlled cooling to target and freeze fat cells. During treatment, a specialised applicator is placed on the target area, cooling the fat cells without harming surrounding tissues. Over time, the cooled fat cells undergo apoptosis (cell death) and are gradually eliminated by the body's natural metabolic processes.

Zeltiq has been extensively studied and has shown effectiveness in reducing fat in clinical trials. Many individuals have reported positive results from the procedure. However, individual experiences may vary.

Zeltiq was developed by scientists at Harvard University who noticed that cold exposure could selectively target and reduce fat cells. It received FDA clearance for use in cosmetic procedures in 2010.

Zeltiq is a proprietary technology and brand name for cryolipolysis-based fat reduction. CoolSculpting, the most well-known brand of cryolipolysis, is a trademarked term associated with the Zeltiq technology.

Zeltiq treatments are typically performed by licensed medical professionals, such as dermatologists or plastic surgeons, who have received specialised training in the procedure.

Training in Zeltiq procedures is typically provided by the manufacturer and may be available to medical professionals who wish to offer the treatment. Training may include hands-on instruction and certification.

The Zeltiq system includes a range of applicators designed for specific treatment areas. It also includes a cooling system that delivers controlled cooling to the targeted fat cells.

Zeltiq treatments can be performed in medical offices, medispas, and specialised aesthetic centres. Facilities should have the necessary equipment and a clean, safe environment for patient care.